← Eichor
Study identifier: NCT07425574 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults

Condition: Stargardt Disease · Stargardt Macular Dystrophy · Stargardt-like Macular Dystrophy  ·  Sponsor: Astellas Pharma Global Development, Inc.

PhaseN/A
Planned participants90
Who can joinAll sexes, 6 Years to no upper limit
Healthy volunteersNo

About this study

Macular dystrophies are a group of inherited eye conditions that affect the macula. The macula is in the center of the retina, the light sensitive part at the back of the eye. In people with macular dystrophies, some of the cells in the macula gradually stop working and may die over time. This leads to vision loss in the center of the eye. Side vision (peripheral vision) is mostly unaffected. Stargardt disease (STGD) is a type of macular dystrophy which is caused by 1 faulty gene (ABCA4). Vision loss most typically happens in childhood, but many people do not develop it until they are adults. As well as STGD, there are other macular dystrophies that look very similar to STGD but that are caused by many other different genes. Together, STGD and STGD-like conditions can be called STGD-type macular dystrophies. This is because they look the same clinically and have similar symptoms. Since different genes can cause these conditions, genetic testing is the only way to be sure which specific condition a person has. In this study, researchers want to learn if the disease progresses in a similar way in people with STGD and STGD-like macular dystrophies. People taking part in the study will continue to manage their condition, as agreed with their own doctor. People will visit their clinic every 6 months to have various standard eye tests and imaging. The information collected will include questions about people's wellbeing, general health, medication and supplements taken, and daily …

This description comes directly from the study's public registry record.

Talk to the study team

Astellas Pharma Global Development, Inc.  ·  800-888-7704  ·  Astellas.registration@astellas.com

Always discuss trial participation with your own doctor first.

Locations (12)

Associated Retina ConsultantsPhoenix, Arizona, United StatesRecruiting
Stanford University School of MedicinePalo Alto, California, United StatesRecruiting
University of California Health - UC DavisSacramento, California, United StatesRecruiting
University of Illinois Chicago - UI HealthChicago, Illinois, United StatesRecruiting
University of Michigan Health - Kellogg Eye CenterAnn Arbor, Michigan, United StatesRecruiting
Deep Blue RetinaSouthaven, Mississippi, United StatesRecruiting
Duke Eye CenterDurham, North Carolina, United StatesRecruiting
Casey Eye Institute - Oregon Health & Science UniversityPortland, Oregon, United StatesRecruiting
Wills Eye Physicians - Mid Atlantic RetinaPhiladelphia, Pennsylvania, United StatesRecruiting
University of Pittsburgh Medical CenterPittsburgh, Pennsylvania, United StatesRecruiting
Retina Foundation of the SouthwestDallas, Texas, United StatesRecruiting
University of Utah Health - John A Moran Eye CenterSalt Lake City, Utah, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07425574